Eurycomanone (Pasakbumin A)
(Synonyms: 宽缨酮,Pasakbumin A) 目录号 : GC32430A quassinoid with diverse biological activities
Cas No.:84633-29-4
Sample solution is provided at 25 µL, 10mM.
Eurycomanone is a quassinoid originally isolated from E. longifolia that has diverse biological activities.1 It is active against the W2 and D6 clones of P. falciparum (IC50s = 0.015 and 0.026 ?g/ml, respectively).2 Eurycomanone induces lipolysis in 3T3-L1 adipocytes with an EC50 value of 14.6 ?M, an effect that can be blocked by the protein kinase A (PKA) inhibitor H-89 .3 It induces cell cycle arrest at the G2/M phase and apoptosis in HepG2 cells when used at a concentration of 5 ?g/ml.4 It reduces estrogen release and increases testosterone release in isolated rat Leydig cell-rich testicular interstitial cell preparations when used at concentrations of 1 and 10 ?M.5 Eurycomanone (1 mg/kg, i.p.) decreases gastric acid secretion and lesion size in rat models of indomethacin-, water immersion stress-, or pyloric ligation-induced ulcer formation.6
1.Darise, M., Kohda, H., Mizutani, K., et al.Eurycomanone and eurycomanol, quassinoids from the roots of Eurycoma longifoliaPhytochemistry21(8)2091-2093(1982) 2.Kuo, P.-C., Damu, A.G., Lee, K.-H., et al.Cytotoxic and antimalarial constituents from the roots of Eurycoma longifoliaBioorg. Med. Chem.12(3)537-544(2004) 3.Lahrita, L., Hirosawa, R., Kato, E., et al.Isolation and lipolytic activity of eurycomanone and its epoxy derivative from Eurycoma longifoliaBioorg. Med. Chem.25(17)4829-4834(2017) 4.Zakaria, Y., Rahmat, A., Pihie, A.H.L., et al.Eurycomanone induce apoptosis in HepG2 cells via up-regulation of p53Cancer Cell Int.9(2009) 5.Low, B.-S., Choi, S.-B., Wahab, H.A., et al.Eurycomanone, the major quassinoid in Eurycoma longifolia root extract increases spermatogenesis by inhibiting the activity of phosphodiesterase and aromatase in steroidogenesisJ. Ethnopharmacol.149(1)201-207(2013) 6.Tada, H., Yasuda, F., Otani, K., et al.New antiulcer quassinoids from Eurycoma longifoliaEur. J. Med. Chem.26(3)345-349(1991)
Cas No. | 84633-29-4 | SDF | |
别名 | 宽缨酮,Pasakbumin A | ||
Canonical SMILES | O[C@@]1([C@H]2O)[C@@]34[C@@]([C@](OC4)(O)[C@H](O)C1=C)([H])[C@]([C@@](C(C)=CC5=O)([H])C[C@@]3([H])OC2=O)([C@@H]5O)C | ||
分子式 | C20H24O9 | 分子量 | 408.4 |
溶解度 | DMSO: 16.67 mg/mL (40.82 mM) | 储存条件 | Store at -20°C,protect from light |
General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。 为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。 |
||
Shipping Condition | 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。 |
制备储备液 | |||
1 mg | 5 mg | 10 mg | |
1 mM | 2.4486 mL | 12.2429 mL | 24.4858 mL |
5 mM | 0.4897 mL | 2.4486 mL | 4.8972 mL |
10 mM | 0.2449 mL | 1.2243 mL | 2.4486 mL |
第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量) | ||||||||||
给药剂量 | mg/kg | 动物平均体重 | g | 每只动物给药体积 | ul | 动物数量 | 只 | |||
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方) | ||||||||||
% DMSO % % Tween 80 % saline | ||||||||||
计算重置 |
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL saline,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。
Quality Control & SDS
- View current batch:
- Purity: >98.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet